YEH YUNG-PING (Chief Innovation Officer) purchased 8.9% of their position (1K shares) of VYANT BIO, INC. on the open market
Open‑market purchase worth $2.6K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/27/2021ACC: 0001493152-21-021378
DirectorOfficer· Chief Innovation Officer
Since Mar 2021
+1K
Net shares
Net buyer
$2.6K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
1K acquired
Non-Derivative Transactions1
Common Stock, $0.0001 par value
Direct
Shares
+1K
Price / share
$2.64
Trade value
$2.64K
% of position
8.9%
8/25/2021
11.26K→12.26K
Total
Net shares
+1K
Net value
$2.64K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value Direct | 8/25/2021 | P · Purchase | +1K | $2.64 | $2.64K | 8.9% | 11.26K | 12.26K |
| Total | +1K | $2.64K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock, $0.0001 par value
IndirectShares owned1.32M
Total
1.32M indirect1.32M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, $0.0001 par value | 1.32M | Indirect |
| Total | 1.32M | 1.32M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported